Table 2.
Indications |
---|
Diagnosis of ischemic stroke causing a measurable neurological deficit |
Onset of symptoms <4.5 h before initiation of treatment |
CONTRAINDICATIONS |
Clinical |
Sustained hypertension above 180/110 mm Hg |
Symptoms suggestive of subarachnoid hemorrhage |
Previous history of intracranial hemorrhage |
ST elevation myocardial infarction within the previous 3 months |
Major head trauma or stroke within the previous 3 months |
Major surgery within the previous 14 days |
Gastrointestinal or urinary tract hemorrhage within the previous 21 days |
Arterial puncture at a non-compressible site within the previous 7 days |
Active bleeding or acute traumatic fracture on examination |
Seizure at onset with suspected postictal deficits |
Minor or rapidly improving neurological deficits |
Radiological |
Head CT showing hemorrhage or multilobar infarction (i.e., hypodensity involving >1/3 of the cerebral hemisphere |
Laboratory |
oral anticoagulation with INR >1.7* |
Heparin within previous 48 h with elevated current aPTT |
Platelet count <100,000 per mm3 |
Blood glucose level <50 mg/dL (2.7 mmol/L) at presentation with improving deficits following correction of hypoglycemia |
Additional contraindications for treatment between 3 and 4.5 h |
Age >80 years |
Very severe deficits at onset (NIHSS score >25) |
Combination of previous stroke and diabetes mellitus |
*Oral anticoagulation regardless of current INR should be considered a contraindication for treatment between 3 and 4.5 h.